Sz-Chi Chiu

Dosing Pattern and Early Cumulative Dose of Liposomal Irinotecan in Metastatic Pancreatic Cancer: A Real-World Multicenter Study

Chung-Pin Li, C. Yen, Li‐Tzong Chen, 2022, Frontiers in Oncology.

Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5‐fluorouracil and leucovorin

D. Chan, Chung-Pin Li, C. Yen, 2022, Journal of hepato-biliary-pancreatic sciences.

Predictive value of albumin combined with neutrophil-to-lymphocyte ratio for efficacy and safety profiles in patients with pancreatic ductal adenocarcinoma receiving liposomal irinotecan plus 5-fluorouracil and leucovorin.

D. Chan, Chung-Pin Li, C. Yen, 2022, American journal of cancer research.

Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer.

N. Chiang, Cheng-Ming Peng, Yung-Yeh Su, 2024, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer

D. Chan, Chung-Pin Li, C. Yen, 2023, Cancers.

Adding-on nivolumab to chemotherapy-stabilized patients is associated with improved survival in advanced pancreatic ductal adenocarcinoma.

K. Yeh, Y. Tien, Sz-Chi Chiu, 2024, Cancer immunology, immunotherapy : CII.